In the remote, windswept reaches of rural Iceland, a Danish-educated anthropologist named Fiona Frenzen is currently teaching elementary and high school students. To an outside observer, her life appears to be a testament to the adventurous spirit—a woman who moved to the Arctic to embrace raw nature. However, just two years ago, Frenzen was a patient in a psychiatric ward, struggling with a debilitating condition that many modern physicians still fail to recognize: protracted antidepressant withdrawal syndrome.
Her story, recently highlighted in an interview with author Brooke Siem for the Mad in America podcast, serves as a profound case study in the complexities of psychiatric over-medication, the physical toll of long-term SSRI use, and the arduous path toward reclaiming one’s autonomy from the medical system.
Main Facts: The Reality of Iatrogenic Harm
Fiona Frenzen’s journey is emblematic of a growing cohort of patients who find that the very treatments intended to stabilize them eventually become the source of their greatest suffering. After over a decade on Sertraline (commonly known as Zoloft), Frenzen attempted to discontinue the medication under medical supervision. The result was not a "relapse" of her original OCD and anxiety, but a violent physiological and neurological collapse known as withdrawal.
Key elements of her case include:
- High-Dose Prescription: Frenzen was maintained on 200mg of Sertraline, a dose that pushes the boundaries of therapeutic efficacy relative to serotonin receptor occupancy.
- Physical Systemic Impact: Long-term use was linked to thyroid dysfunction (hypothyroidism) and severe gastrointestinal issues, later diagnosed as lymphocytic microscopic colitis.
- Withdrawal Mismanagement: A "cold turkey" jump from 50mg—a dose often considered low by doctors but high in terms of brain chemistry—led to akathisia, flashbacks, and hospitalization.
- The "Benzo Trap": To manage withdrawal symptoms, she was prescribed benzodiazepines, leading to a secondary addiction and a harrowing detoxification process.
A Chronology of Escalation and Collapse
The Early Years and the First Prescription
Frenzen’s mental health challenges did not emerge in a vacuum. Born in Germany and raised in Denmark, she experienced significant trauma at the age of five following the death of her mother. While she lived with anxiety and Obsessive-Compulsive Disorder (OCD) for decades, she remained unmedicated and functional, pursuing a Master’s degree in anthropology and working in social services.
It was not until age 25, following a period of chronic sleep deprivation and noise-related anxiety, that a General Practitioner prescribed 100mg of Sertraline. While the drug initially provided some relief, it also marked the beginning of a decade-long dependence where the underlying trauma remained unaddressed, and the medication became a permanent fixture of her daily life.
The Dosage Spiral
During a particularly traumatic period while working as a teacher in Germany, Frenzen’s OCD symptoms spiked. She became gripped by a phobia that her students would fall out of windows, leading to compulsive checking behaviors. Despite seeking inpatient treatment, the medical response was primarily pharmacological: her dose was doubled to 200mg.
"If you know about receptor occupancy, it doesn’t really make sense to be on 200 milligrams," Frenzen noted in her interview. Indeed, research into SSRIs shows a hyperbolic curve where the majority of serotonin transporters are saturated at much lower doses. Increasing from 100mg to 200mg offers diminishing returns for the brain while significantly increasing the burden on the body’s metabolic and endocrine systems.
The Physical Toll
During her years on the high-dose regimen, Frenzen’s health began to deteriorate. She suffered from chronic exhaustion, requiring her sister to call and wake her every morning. More distressingly, she developed severe gut inflammation and thyroid failure, requiring Eltroxin. At the time, no physician linked these systemic failures to her psychiatric medication.
The Crisis of Withdrawal: "Hell Started"
In 2021, feeling that the medication was "blocking" her ability to think and heal, Frenzen began a taper. Under the guidance of a psychiatrist, she reduced her dose to 50mg. Feeling better at this lower dose, she asked if she could stop entirely. The psychiatrist agreed.
This "jump" from 50mg proved catastrophic. In the world of psychiatric drug tapering, the final milligrams are the most difficult because they represent a large percentage of receptor occupancy. Frenzen was plunged into a state of neurological instability characterized by:
- Brain Zaps: Electrical shock sensations in the head.
- Akathisia: A state of severe inner restlessness that forced her to pace her yard for hours.
- Loss of Autonomy: For the first time in her life, the formerly independent traveler could not be alone.
- Psychological Flashbacks: Traumatic memories from her childhood resurfaced with terrifying intensity.
When she reported these symptoms, her psychiatrist misdiagnosed them as a return of her original mental illness rather than withdrawal. "Fiona, you need to be on medication… apparently you’re really sick," he told her. This gaslighting—a common experience for withdrawal sufferers—nearly led to a lifetime of permanent disability.
The Path to Recovery: Function as Therapy
Frenzen’s recovery was not found in a hospital, but in the rejection of the "sick role." After a grueling period that included a three-month hospitalization and a difficult benzodiazepine detox, she turned to alternative sources of information. She discovered the work of Danish researcher Anders Sørensen and British psychiatrist Mark Horowitz, both of whom specialize in safe, hyperbolic tapering.
The Icelandic Pivot
Throughout her crisis, Frenzen held onto a dream of living in Iceland. In the fall of 2023, despite lingering withdrawal symptoms and the fears of her medical team, she accepted a teaching position in a rural Icelandic village.
This move proved to be the ultimate rehabilitation. "What really helped me was getting out of this role of being ‘sick Fiona,’" she explained. By taking on the responsibility of a homeroom teacher for 8th graders and teaching Danish across multiple grade levels, Frenzen forced her brain to build new pathways. The transition from a "patient" to a "contributor" shifted her focus from her internal symptoms to her external environment.
Supporting Data: The Science of Withdrawal
Frenzen’s experience is supported by a growing body of scientific literature that challenges the "chemical imbalance" theory and the ease of discontinuation.
- Receptor Occupancy: Research published in The Lancet Psychiatry by Dr. Mark Horowitz highlights that because SSRI hyperbolic binding, even a small dose (like 2mg or 5mg) can have a significant effect on the brain. Jumping from 50mg of Sertraline often results in a "crash" because the brain cannot adapt quickly enough to the sudden drop in serotonin levels.
- The Gut-Brain Axis: The discovery of Frenzen’s microscopic colitis aligns with the fact that 95% of the body’s serotonin is located in the gut. Long-term SSRI use can alter the gut microbiome and the integrity of the intestinal lining, leading to chronic inflammatory conditions.
- Protracted Withdrawal: A 2019 study published in Addictive Behaviors found that over 50% of people stopping antidepressants experience withdrawal, and nearly half of those describe the symptoms as severe.
Official Responses and Medical Gaslighting
A significant hurdle in Frenzen’s journey was the disconnect between her lived experience and the medical framework of her doctors. When she presented with flashbacks, one psychiatrist dismissed her trauma, stating it didn’t meet the "six criteria" for PTSD.
This clinical rigidity often prevents patients from receiving the trauma-informed care they need. Furthermore, the tendency to prescribe benzodiazepines to "mask" SSRI withdrawal symptoms remains a pervasive and dangerous practice in modern psychiatry. In Germany, where Frenzen sought treatment, the medical community acknowledges benzo addiction as being as severe as heroin addiction, yet the system continues to facilitate the initial dependency.
Implications: An Anthropological View of Mental Health
As a qualified anthropologist, Fiona Frenzen now views her experience through a societal lens. She dreams of using her degree to research the "social death" that occurs when a person is indefinitely labeled as "mentally ill" and "medication-dependent."
Redefining "Sick"
Frenzen argues for a broader acceptance of human "weirdness" and emotional pain. "Are we sick when we are grieving and being sad and anxious?" she asks. Her journey suggests that many psychiatric symptoms are not biological malfunctions, but logical responses to life events—suicide, adoption, loss—that require processing rather than numbing.
The Power of Acceptance
Now two years off all psychiatric medication, Frenzen continues to manage the physical legacy of her time on Sertraline, including a strict ketogenic diet to manage her colitis. However, her perspective has shifted from seeking a "cure" to practicing radical acceptance.
"I think the magic of acceptance is accepting where we’re at right now without projecting that onto the future," Brooke Siem noted during the interview. For Frenzen, this means accepting that she may still have "dark winters" and difficult memories, but she now possesses the tools and the clarity to face them without a chemical buffer.
Conclusion
Fiona Frenzen’s story is a harrowing yet hopeful reminder of the resilience of the human spirit. It highlights the urgent need for the medical community to recognize the reality of antidepressant withdrawal and the importance of "deprescribing" with the same care as prescribing. By moving to the edge of the world to teach, Frenzen did more than just find a job; she reclaimed her identity from a system that had written her off as chronically ill. Her journey from the psychiatric ward to the Arctic serves as a beacon for others lost in the "hell" of withdrawal, proving that there is, indeed, a way through to the other side.
